SpaceX has pulled off another successful test flight of Starship, the world’s largest and most powerful rocket. If you're enjoying this article, consider supporting our award-winning journalism by ...

Mattel has set out to bring many of its most famous franchises to theaters, a move that's not overly surprising after Barbie became an immediate critical and commercial success in 2023, grossing over ...

SpaceX launched Starship Monday night at approximately 7:23 p.m. Eastern time, marking its 11th flight test. According to SpaceX, this flight test was meant to "build on the successful demonstrations ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

IE University provides funding as a founding partner of The Conversation ES. IE University provides funding as a member of The Conversation EUROPE. While these may seem like disconnected events, in ...

In a thrilling display of pace and precision, India’s spearhead Jasprit Bumrah found himself at the center of a heated DRS controversy during the second Test against West Indies at the Arun Jaitley ...

Russian dictator Vladimir Putin supervised what he said was a planned test of Russia’s nuclear forces on land, sea and in the air to assess his nation’s readiness on Wednesday. “Today, we are ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

The Lucid Gravity SUV is rated to be a long-distance champion at 450 miles of EPA-rated range. But State of Charge's Tom Moloughney did the usual 70 mph run down to nearly empty, and achieved 345 ...

MOSCOW, Oct 22 (Reuters) - President Vladimir Putin on Wednesday oversaw a test of Russia's nuclear forces on land, sea and air to rehearse their readiness and command structure. The test included the ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...